|
|
Blood, 28 May 2009, Vol. 113, No. 22, pp. 5497-5505.
Prepublished online as a Blood First Edition Paper on March 19, 2009; DOI 10.1182/blood-2008-11-190231.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression
Gareth A. D. Hardy1,
Scott F. Sieg2,3,
Benigno Rodriguez2,3,
Wei Jiang2,
Robert Asaad2,3,
Michael M. Lederman13, and
Clifford V. Harding1,3
1 Department of Pathology,
2 Division of Infectious Disease, and
3 Center for AIDS Research, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH
Type I interferon (IFN /β) plays a complex role in HIV-1 infection and has been proposed alternately to have roles in either disease protection or progression. Although IFN /β plays crucial roles in regulating monocytes and dendritic cells, responsiveness of these cells to IFN /β in HIV-1 infection is poorly understood. We report significant defects in IFN /β receptor (IFN /βR) expression, IFN signaling, and IFN -induced gene expression in monocytes from HIV-1–infected subjects. IFN /βR expression correlated directly with CD4+ T-cell count and inversely with HIV-1 RNA level and expression of CD38 by memory (CD45RO+) CD8+ T cells, a measure of pathologic immune activation in HIV-1 infection associated with disease progression. In addition, monocytes from HIV-1–infected persons showed diminished responses to IFN , including decreased induction of phosphorylated STAT1 and the classical interferon-stimulated gene produces MxA and OAS. These IFN responses were decreased regardless of IFN /βR expression, suggesting that regulation of intracellular signaling may contribute to unresponsiveness to IFN /β in HIV-1 disease. Defective monocyte responses to IFN /β may play an important role in the pathogenesis of HIV-1 infection, and decreased IFN /βR expression may serve as a novel marker of disease progression.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. J. Conry, K. A. Milkovich, N. L. Yonkers, B. Rodriguez, H. B. Bernstein, R. Asaad, F. P. Heinzel, M. Tary-Lehmann, M. M. Lederman, and D. D. Anthony
Impaired Plasmacytoid Dendritic Cell (PDC)-NK Cell Activity in Viremic Human Immunodeficiency Virus Infection Attributable to Impairments in both PDC and NK Cell Function
J. Virol.,
November 1, 2009;
83(21):
11175 - 11187.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|